The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Molecular mechanisms regulating NLRP3 inflammasome activation
Open accessAbstract
Inflammasomes are multi-protein signaling complexes that trigger the activation of inflammatory caspases and the maturation of interleukin-1β. Among various inflammasome complexes, the NLRP3 inflammasome is best characterized and has been linked with various human autoinflammatory and autoimmune diseases. Thus, the NLRP3 inflammasome may be a promising target for anti-inflammatory therapies. In this review, we summarize the current understanding of the mechanisms by which the NLRP3 inflammasome is activated in the cytosol. We also describe the binding partners of NLRP3 inflammasome complexes activating or inhibiting the inflammasome assembly. Our knowledge of the mechanisms regulating NLRP3 inflammasome signaling and how these influence inflammatory responses offers further insight into potential therapeutic strategies to treat inflammatory diseases associated with dysregulation of the NLRP3 inflammasome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In these circumstances, ATP may act as DAMP, which activates the nuclear transcription factor NF-κB resulting in expression upregulation of pro-IL-1β and pro-IL-18 and the NLRP3 protein [16, 71].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [71]
In the citing paper
“Consequently, there is an activation of caspase-1 and maturation of IL-1β and IL-18, resulting in pro-inflammatory cytokine release [16, 20, 52, 71, 73].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [71]
Citations
Cites
1 retracted
UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis
Moon, J.-S., Lee, S., Park, M.-A., Siempos, I. I., Haslip, M., Lee, P. J., Yun, M., Kim, C. K., Howrylak, J., Ryter, S. W., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78253 · Cited by 238
RetractedMartinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,444
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,001
Jia, X., Cao, B., An, Y., Zhang, X., & Wang, C. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.017 · Cited by 70
Wong, W.-T., Li, L., Rao, Y. K., Yang, S., Cheng, S., Lin, W., Cheng, C., Chen, A., & Hua, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01920 · Cited by 69
The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer
Wang, M., Jiang, S., Zhang, Y., Li, P., & Wang, K. (2019) · Cancers · doi:10.3390/cancers11091313 · Cited by 69
NLRP3 inflammasome: a new therapeutic target for high-risk reproductive disorders?
Zhou, F., Li, C., & Zhang, S. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001214 · Cited by 71
Hao, W., Wu, J., Yuan, N., Gong, L., Huang, J., Ma, Q., Zhu, H., Gan, H. T., Da, X., Deng, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.619103 · Cited by 70
ALDOA maintains NLRP3 inflammasome activation by controlling AMPK activation
Bai, D., Du, J., Bu, X., Cao, W., Sun, T., Zhao, J., Zhao, Y., & Lu, N. (2021) · Autophagy · doi:10.1080/15548627.2021.1997051 · Cited by 71
Li, C., Zeng, Q., Chen, M., Xu, L., Zhang, C., Mai, F., Zeng, C., He, X., & Ouyang, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00290 · Cited by 72
Iorio, R., Celenza, G., & Petricca, S. (2022) · Antioxidants · doi:10.3390/antiox11061199 · Cited by 75
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Jiang, Y., Zhao, T., Zhou, X., Yu, X., Gutiérrez‐Castrellón, P., & Ma, X. (2022) · MedComm · doi:10.1002/mco2.154 · Cited by 77
The Role of Post-Translational Modifications in Regulation of NLRP3 Inflammasome Activation
Xia, J., Jiang, S., Dong, S., Liao, Y., & Zhou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076126 · Cited by 74
Control of Inflammasome Activation by Phosphorylation
Gong, T., Jiang, W., & Zhou, R. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.06.008 · Cited by 68
Frame, J. M., Kubaczka, C., Long, T. L., Esain, V., Soto, R. A., Hachimi, M., Jing, R., Shwartz, A., Goessling, W., Daley, G. Q., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.07.015 · Cited by 68
Chen, S., Zhou, C. L., Yu, H., Tao, L., An, Y., Zhang, X., Wang, Y., Wang, Y., & Xiao, R. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00014 · Cited by 66
Moltrasio, C., Romagnuolo, M., & Marzano, A. V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1007705 · Cited by 71
Questions and controversies in innate immune research: what is the physiological role of NLRP3?
Coll, R. C., O'Neill, L. A. J., & Schroder, K. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.19 · Cited by 69
Shi, L., Zhao, Y., Fei, C., Guo, J., Jia, Y., Wu, D., Wu, L., & Chang, C. (2019) · Aging · doi:10.18632/aging.102409 · Cited by 68
Zhang, X., Fu, Y., Li, H., Shen, L., Chang, Q., Pan, L., Hong, S., & Yin, X. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13464 · Cited by 67
Frank, M. G., Fonken, L. K., Watkins, L. R., & Maier, S. F. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.063 · Cited by 70
Li, X., Li, H., Cai, D., Li, P., Jin, J., Jiang, X., Li, Z., Tian, L., Chen, G., Sun, J., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111944 · Cited by 69
Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis
Shao, S., Chen, C., Shi, G., Zhou, Y. J., Wei, Y., Fan, N., Yang, Y., Wu, L., & Zhang, T. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107880 · Cited by 67
The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
Arioz, B. I., Tarakcioglu, E., Olcum, M., & Genç, Ş. (2021) · Antioxidants · doi:10.3390/antiox10071020 · Cited by 67
Zuo, C., Cao, H., Feng, F., Guo, L., Huang, Y., Zhu, L., Gu, Z., Yang, Y., Chen, J., Jiang, Y., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108788 · Cited by 66
Nanomaterials and Innate Immunity: A Perspective of the Current Status in Nanosafety
Cronin, J., Jones, N., Thornton, C. A., Jenkins, G. J. S., Doak, S. H., & Clift, M. J. D. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00051 · Cited by 67
Schoeman, D., & Fielding, B. C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.02086 · Cited by 66
Xiao, G., Zhuang, W., Wang, T., Lian, G., Luo, L., Ye, C., Wang, H., & Xie, L. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15745 · Cited by 65
Dolunay, A., Şenol, Ş. P., Temiz-Reşitoğlu, M., Güden, D. S., Sari, A. N., Şahan-Fırat, S., & Tunçtan, B. (2016) · Inflammation · doi:10.1007/s10753-016-0483-3 · Cited by 65
The NLRP3 Inflammasome: An Important Driver of Neuroinflammation in Hemorrhagic Stroke
Shao-jun, Y., Shao, G., Chen, J., & Gong, J. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0526-9 · Cited by 68
Poon, W.-L., Alenius, H. T., Ndika, J., Fortino, V., Kolhinen, V., Meščeriakovas, A., Wang, M., Greco, D., Lähde, A., Jokiniemi, J. K., et al. (2017) · Nanotoxicology · doi:10.1080/17435390.2017.1382600 · Cited by 65
Hung, S.-C., Huang, P.-R., Almeida-da-Silva, C. L. C., Atanasova, K. R., Yilmaz, Ö., & Ojcius, D. M. (2017) · Microbes and Infection · doi:10.1016/j.micinf.2017.09.014 · Cited by 65
Ye, J., Zeng, B., Zhong, M.-Y., Li, H., Xu, L., Shu, J., Wang, Y., Yang, F., Zhong, C.-S., Ye, X.-J., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.07.014 · Cited by 63
Darwesh, A. M., Bassiouni, W., Sosnowski, D. K., & Seubert, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107703 · Cited by 66
Regulation of the NLRP3 Inflammasome by Posttranslational Modifications
Zangiabadi, S., & Sater, A. A. A. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100734 · Cited by 63
Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression
Han, Q.-Q., Li, W., Chen, P., Wang, L., Bao, X., Huang, R., Liu, G., & Chen, X. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.390964 · Cited by 67
NLRP3 inflammasome in health and disease (Review)
Wang, H., Ma, L., Su, W., Liu, Y., Xie, N., & Liu, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5489 · Cited by 70
Aspartate Metabolism Facilitates IL-1β Production in Inflammatory Macrophages
Wang, H., Zheng, X., Liu, B., Xia, Y., Xin, Z., Deng, B., He, L., Deng, J., & Ren, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753092 · Cited by 68
NLRP3-mediated pyroptosis in diabetic nephropathy
Wan, J., Liu, D., Pan, S., Zhou, S., & Liu, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.998574 · Cited by 66
Ho, S.-C., & Chang, Y.-H. (2018) · Molecules · doi:10.3390/molecules23020466 · Cited by 63
Gao, W., Wang, W., Liu, G., Zhang, J., Yang, J. M., & Deng, Z. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0342-z · Cited by 64
An emerging interplay between extracellular vesicles and cytokines
Aiello, A., Giannessi, F., Percario, Z. A., & Affabris, E. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.12.003 · Cited by 63
Spirulina maxima extract prevents activation of the NLRP3 inflammasome by inhibiting ERK signaling
Chei, S., Oh, H., Song, J.-H., Seo, Y., Lee, K., Kim, K., & Lee, B.-Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-58896-6 · Cited by 63
Tane, A., Khalili‐Tanha, G., Esmaeili, A., Mobasheri, L., Kooshkaki, O., Jafari, S., Shokouhifar, A., & Sarab, G. A. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01401-0 · Cited by 63
Wang, Y., Mishra, A., & Brinton, R. D. (2020) · F1000Research · doi:10.12688/f1000research.21599.1 · Cited by 65
Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome
Dong, W., Jia, C., Li, J., Zhou, Y., Luo, Y., Liu, J., Zhao, Z., Zhang, J., Lin, S., & Chen, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.783706 · Cited by 62
Innate immunomodulation to trypanosomatid parasite infections
Dos-Santos, A. L. A., Carvalho‐Kelly, L. F., Dick, C. F., & Meyer‐Fernandes, J. R. (2016) · Experimental Parasitology · doi:10.1016/j.exppara.2016.05.005 · Cited by 61
Relationships Between Ion Channels, Mitochondrial Functions and Inflammation in Human Aging
Strickland, M., Yacoubi‐Loueslati, B., Bouhaouala‐Zahar, B., Pender, S. L. F., & Larbi, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00158 · Cited by 64
Lin, C., Gao, Z., Zheng, Y., Ye, T., Wang, Z., Wang, P., Li, M., Dong, B., Yang, W. P., Li, Q., et al. (2020) · Aging · doi:10.18632/aging.103038 · Cited by 61
Fu, Q., Li, J., Qiu, L., Ruan, J., Mao, M., Li, S., & Mao, Q.-H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106317 · Cited by 61
The Interplay between Autophagy and NLRP3 Inflammasome in Ischemia/Reperfusion Injury
Lv, S., Liu, H., & Wang, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168773 · Cited by 60
Estrogen plays an important role by influencing the NLRP3 inflammasome
Dong, W., Peng, Q., Liu, Z., Xie, Z., Guo, X., Li, Y., & Chen, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115554 · Cited by 68
GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics
Tang, T., Gong, T., Jiang, W., & Zhou, R. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.07.002 · Cited by 64
Rodrigues, F. T. S., de Souza, M. R. M., Lima, C. N. D. C., da Silva, F. E. R., Costa, D. V. D. S., dos Santos, C. C., Miyajima, F., de Sousa, F. C. F., Vasconcelos, S. M. M., Barichello, T., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.10.003 · Cited by 64
Mitochondria in Focus: From Function to Therapeutic Strategies in Chronic Lung Diseases
Caldeira, D. D. A. F., Weiss, D. J., Rocco, P. R. M., Silva, P. L., & Cruz, F. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.782074 · Cited by 59
Campisano, S., la Colla, A. B., Echarte, S. M., & Chisari, A. N. (2019) · Nutrition Research Reviews · doi:10.1017/s0954422418000239 · Cited by 59
The Role of Connexin and Pannexin Channels in Perinatal Brain Injury and Inflammation
Zhou, K. Q., Green, C. R., Bennet, L., Gunn, A. J., & Davidson, J. O. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00141 · Cited by 61
TMA/TMAO in Hypertension: Novel Horizons and Potential Therapies
Zhang, W., Wang, Y., Zhang, A., Ding, Y., Zhang, X., Jia, Q.-J., Zhu, Y., Li, Y., Lv, S., & Zhang, J. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10115-x · Cited by 59
Host cell-intrinsic innate immune recognition of SARS-CoV-2
Madden, E. A., & Diamond, M. S. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.11.002 · Cited by 60
Revisiting Regulated Cell Death Responses in Viral Infections
Balaya, R. D. A., Prasad, T. S. K., & Kandasamy, R. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137023 · Cited by 60
Luo, M., Hu, L., Li, D., Wang, Y., He, Y., Zhu, L., & Ren, W. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.06.035 · Cited by 59
Glibenclamide inhibits NLRP3 inflammasome-mediated IL-1β secretion in human trophoblasts
Tamura, K., Ishikawa, G., Yoshie, M., Ohneda, W., Nakai, A., Takeshita, T., & Tachikawa, E. (2017) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2017.09.032 · Cited by 59
The rOX‐stars of inflammation: links between the inflammasome and mitochondrial meltdown
Holley, C. L., & Schroder, K. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1109 · Cited by 61
Yan, C., Yan, H., Mao, J., Liu, Y., Li, X., Zhao, H., Shen, J., Cao, Y. W., Gao, Y., Li, K., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.557170 · Cited by 58
Tang, T., Li, P., Zhou, X., Wang, R., Fan, X., Yang, M., & Qi, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741839 · Cited by 61
A review: Pharmacology and pharmacokinetics of Schisandrin A
Fu, K., Zhou, H., Wang, C., Gong, L., Ma, C., Zhang, Y., & Li, Y. (2022) · Phytotherapy Research · doi:10.1002/ptr.7456 · Cited by 60
Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
Lu, R., Zhang, L., & Yang, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1018848 · Cited by 58
Luo, Y., Lü, J., Ruan, W., Guo, X., & Chen, S. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.01.027 · Cited by 58
Liu, Q., Didi, W., Yang, X., Ma, F., Han, W., Hu, J., & Mei, Q. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac152 · Cited by 58
Demirel, I., Persson, A., Brauner, A., Särndahl, E., Kruse, R. L., & Persson, K. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00081 · Cited by 57
Xin, L., Che, B., Zhai, B., Luo, Q., Zhang, C., Wang, J., Wang, S., Fan, G., Liu, Z., Feng, J., et al. (2018) · Inflammation · doi:10.1007/s10753-018-0928-y · Cited by 57
The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
Feng, Y.-S., Tan, Z., Wu, L., Dong, F., & Zhang, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111428 · Cited by 59
Jorquera, G., Russell‐Guzmán, J., Monsalves‐Álvarez, M., Cruz, G., Valladares-Ide, D., Basualto-Alarcón, C., Barrientos, G. C., Estrada, M., & Llanos, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063254 · Cited by 61
Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome
Bagherniya, M., Khedmatgozar, H., Fakheran, O., Xu, S., Johnston, T. P., & Sahebkar, A. (2021) · Phytotherapy Research · doi:10.1002/ptr.7118 · Cited by 60
Cell death in skin function, inflammation, and disease
Anderton, H., & Alqudah, S. (2022) · Biochemical Journal · doi:10.1042/bcj20210606 · Cited by 64
Su, W., Li, J.-M., Zhang, T., Cao, Z., Hu, T., Zhong, S.-Y., Xu, Z.-Y., Gong, H., & Jiang, C. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110796 · Cited by 57
Ginsenosides for therapeutically targeting inflammation through modulation of oxidative stress
Paik, S., Song, G., & Jo, E. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110461 · Cited by 58
Self-citationThe NLRP 3 inflammasome contributes to host protection during Sporothrix schenckii infection
Gonçalves, A. C., Ferreira, L. S., Manente, F. A., de Faria, C. M. Q. G., Polesi, M. C., de Andrade, C. R., Zamboni, D. S., & Carlos, I. Z. (2017) · Immunology · doi:10.1111/imm.12719 · Cited by 55
Nan, B., Hong, Y.-L., Yang, C., Li, L., & Yuan, Y. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111679 · Cited by 50
Chen, N., Ou, Z.-B., Zhang, W., Zhu, X., Li, P., & Gong, J. (2018) · Cell Proliferation · doi:10.1111/cpr.12487 · Cited by 55
Innate immunity and HPV: friends or foes
Nunes, R. A. L., Morale, M. G., Silva, G. Á. F., Villa, L. L., & Termini, L. (2018) · Clinics · doi:10.6061/clinics/2018/e549s · Cited by 57
Shen, T., Li, X., Loor, J. J., Zhu, Y., Du, X., Wang, X., Xing, D., Shi, Z., Fang, Z., Li, X., et al. (2019) · Journal of Dairy Science · doi:10.3168/jds.2019-16706 · Cited by 58
The NLRP3 Inflammasome and Its Role in T1DM
Sun, X., Pang, H., Li, J., Luo, S., Huang, G., Li, X., Xie, Z., & Zhou, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01595 · Cited by 57
Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages
Nolan, R. A., Reeb, K. L., Rong, Y., Matt, S. M., Johnson, H. S., Runner, K., & Gaskill, P. J. (2019) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100030 · Cited by 54
COVID‐19 immunopathology: From acute diseases to chronic sequelae
Arish, M., Qian, W. G., Narasimhan, H., & Sun, J. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28122 · Cited by 55
Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy
Karan, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03028 · Cited by 55
Panda, C., Voelz, C., Habib, P., Mevissen, C., Pufe, T., Beyer, C., Gupta, S. K., & Slowik, A. (2021) · Cells · doi:10.3390/cells10071652 · Cited by 54
Scarred Lung. An Update on Radiation-Induced Pulmonary Fibrosis
Jarzebska, N., Karetnikova, E. S., Markov, A. G., Kasper, M. E., Rodionov, R. N., & Spieth, P. M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.585756 · Cited by 54
Xu, Z., Wang, H., Qin, Z., Zhao, F., Zhou, L., Xu, L., & Jia, R. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00766-9 · Cited by 53
Nishijima, N., Hirai, T., Misato, K., Aoyama, M., Kuroda, E., Ishii, K. J., Higashisaka, K., Yoshioka, Y., & Tsutsumi, Y. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00379 · Cited by 53
Lin, Z.-H., Wang, S., Chen, L., Zhuang, J.-Y., Ke, Q., Xiao, D.-R., & Lin, W. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00391 · Cited by 53
Liu, Y., Xu, Z., Ma, F., Jia, Y., & Wang, G. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.134 · Cited by 53
Hsieh, C., Li, L., Rao, Y. K., Ju, T., Nai, Y., Chen, Y., & Hua, K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27204 · Cited by 54
Dumont, A., de Rosny, C., Kieu, T., Perrey, S., Berger, H., Fluckiger, A., Muller, T., de Barros, J.-P. P., Pichon, L., Hichami, A., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1723-x · Cited by 54
Impact of pharmacological agents on mitochondrial function: a growing opportunity?
Stoker, M. L., Newport, E., Hulit, J., West, A. P., & Morten, K. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190280 · Cited by 51
Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets
Raman, K. S., & Matsubara, J. A. (2020) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2020.1811350 · Cited by 52
Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis
Jiang, Q., Wang, X., Huang, E., Wang, Q., Wen, C., Yang, G., Lu, L., & Cui, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.816839 · Cited by 55
Iron potentiates microglial interleukin‐1β secretion induced by amyloid‐β
Nnah, I. C., Lee, C., & Wessling‐Resnick, M. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14906 · Cited by 54
Polysaccharides from Armillariella tabescens mycelia ameliorate renal damage in type 2 diabetic mice
Yang, R., Li, Y., Mehmood, S., Yan, C., Huang, Y., Cai, J., Ji, J., Pan, W., Zhang, W., & Chen, Y. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.08.006 · Cited by 51
Xia, B., Tong, Y. A., Xia, C., Chen, C., & Shan, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.577062 · Cited by 52
Zheng, W., He, W., Zhang, Q., Jia, J.-X., Zhao, S., Wu, F.-J., & Cao, X. (2021) · Inflammation · doi:10.1007/s10753-021-01486-z · Cited by 52
Hu, X., Shen, Y., Zhao, Y., Wang, J., Zhang, X., Tu, W., Kaufman, W., Feng, J., & Gao, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767508 · Cited by 55
Rheumatoid arthritis and mitochondrial homeostasis: The crossroads of metabolism and immunity
Liu, C., Jing, W., Su, C.-H., Liu, L., Xinghua, Z., Yuan, B., Xiaozheng, D., & Wang, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1017650 · Cited by 55
Metadata
- Authors
- Jo, E.-K., Kim, J. K., Shin, D.-M., & Sasakawa, C.
- Affiliations
- Chungnam National University (KR)
- Chiba University (JP)
- Corresponding author
- Jo, Eun-Kyeong
- Venue
- Cellular & Molecular Immunology
- Published
- 2015-11-09
- Volume
- 13
- Issue
- 2
- Pages
- 148-159
- ISSN
- 1672-7681 (ISSN-L)
- 2042-0226
- PMC
- PMC4786634
- OpenAlex
- W2118918019
- Cited by
- 1,378
- References
- 139
- Citations by year
- 2026: 127 · 2025: 125 · 2024: 157 · 2023: 162 · 2022: 145 · 2021: 173 · 2020: 171 · 2019: 122 · 2018: 97 · 2017: 61 · 2016: 36
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Cellular and Molecular Immunology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- NLRP3 inflammasome, inflammasome activation, caspase-1, autoinflammatory disease, autoimmune disease, anti-inflammatory therapy, inflammasome assembly, inflammatory diseases
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Autoimmune Diseases, Cytosol, Humans, Inflammation, Signal Transduction, Interleukin-1beta, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review